Johannesen, Langsted, Nordestgaard, & Mortensen (2026). Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease.. JAMA cardiology.
Johannesen, Langsted, Nordestgaard, Mortensen. Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease.. JAMA cardiology. 2026; PMID: 42126847
Johannesen, Langsted, Nordestgaard, et al. Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease.[J]. JAMA cardiology. 2026.
@article{johannesen2026,
author = {Johannesen and Langsted and Nordestgaard and Mortensen},
title = {Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease.},
journal = {JAMA cardiology},
year = {2026},
note = {PMID: 42126847},
}
TY - JOUR AU - Johannesen AU - Langsted AU - Nordestgaard AU - Mortensen TI - Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease. T2 - JAMA cardiology PY - 2026 AN - PMID:42126847 ER -
Non-high-density-lipoprotein (non-HDL) cholesterol and apolipoprotein B (apoB) are better markers of atherosclerotic cardiovascular disease (ASCVD) risk than low-density-lipoprotein cholesterol, but whether non-HDL cholesterol or apoB is superior to the other is less clear.